Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.

× No keyword cloud information.

20 in total

1. Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors: F L Van Muiswinkel; P Eikelenboom
Journal: Drugs Aging Date: 1996-07 Impact factor: 3.923

Review 2. Recent advances in the understanding of dementia.

Authors: P Tyrrell; M Rossor
Journal: Postgrad Med J Date: 1988-02 Impact factor: 2.401

3. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.

Authors: G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; A Romani; A Pola; F Zerbi; F Savoldi
Journal: Eur Arch Psychiatry Neurol Sci Date: 1989

Review 4. Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia.

Authors: R Zappoli; A Versari; M Paganini; G Arnetoli; G C Muscas; P F Gangemi; M G Arneodo; D Poggiolini; F Zappoli; A Battaglia
Journal: Ital J Neurol Sci Date: 1995-09

5. Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

Authors: Kyeong-Ryoon Lee; Yoon-Jee Chae; Han-Joo Maeng; Jeewoo Lee; Dae-Duk Kim; Saeho Chong; Chang-Koo Shim; Suk-Jae Chung
Journal: J Pharmacokinet Pharmacodyn Date: 2011-08-25 Impact factor: 2.745

6. Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable o-phthalaldehyde-sulphite derivatives.

Authors: S J Pearson; C Czudek; K Mercer; G P Reynolds
Journal: J Neural Transm Gen Sect Date: 1991

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.

1. Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Review 2. Recent advances in the understanding of dementia.

3. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.

Review 4. Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia.

5. Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

6. Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable o-phthalaldehyde-sulphite derivatives.

Review 7. Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

8. Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Review 9. Diagnostic and pharmacological approaches in Alzheimer's disease.

10. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.